Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ranibizumab”

533 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 533 results

Testing effectiveness (Phase 2)Study completedNCT02140151
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Southern California Desert Retina Consultants, MC 108
Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Not applicableStudy completedNCT02291887
What this trial is testing

Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

Who this might be right for
Age-Related Macular Degeneration
Associated Retinal Consultants, Michigan 13
Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Post-approval studies (Phase 4)WithdrawnNCT02258009
What this trial is testing

Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Visual Impairment Due to Diabetic Macular Edema
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT02214628
What this trial is testing

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 101
Not applicableEnded earlyNCT00474695
What this trial is testing

Study Evaluating Genotypes Using Lucentis

Who this might be right for
Age-Related Maculopathy
University of Utah 65
Testing effectiveness (Phase 2)WithdrawnNCT02511067
What this trial is testing

Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study

Who this might be right for
Diabetic Macular Edema
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT00390208
What this trial is testing

Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Bay Area Retina Associates 60
Post-approval studies (Phase 4)Study completedNCT01500915
What this trial is testing

FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Institut de la Macula y la Retina 17
Testing effectiveness (Phase 2)Study completedNCT01251978
What this trial is testing

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)

Who this might be right for
Choroidal Melanoma
New England Retina Associates 10
Large-scale testing (Phase 3)UnknownNCT05480293
What this trial is testing

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 446
Not applicableUnknownNCT02126904
What this trial is testing

Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept

Who this might be right for
The Injection Burden
Yokohama City University Medical Center 200
Not applicableStudy completedNCT01638858
What this trial is testing

Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

Who this might be right for
Age-Related Macular Degeneration
University of Luebeck 25
Testing effectiveness (Phase 2)Study completedNCT00606138
What this trial is testing

Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging

Who this might be right for
Proliferative Diabetic Retinopathy
Rush University Medical Center 9
Not applicableStudy completedNCT06173245
What this trial is testing

Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy

Who this might be right for
Subfoveal Choroidal ThicknessIntravitrealRanibizumab+2 more
Egyptian Biomedical Research Network 50
Early research (Phase 1)Study completedNCT00457145
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Large-scale testing (Phase 3)Active Not RecruitingNCT06571045
What this trial is testing

Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Who this might be right for
Diabetic Macular Edema (DME)
EyeBiotech Ltd. 984
Large-scale testing (Phase 3)Study completedNCT01396057
What this trial is testing

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Visual ImpairmentMacular EdemaBranch Retinal Vein Occlusion
Novartis Pharmaceuticals 244
Post-approval studies (Phase 4)UnknownNCT02059772
What this trial is testing

Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
GWT-TUD GmbH 25
Load More Results